News-Medical.Net on MSN

Investigational cancer vaccine shows early promise for cancer prevention in Lynch syndrome

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...
EL PAÍS English

A vaccine to prevent colon cancer shows promising results

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...
The Manila Times

Nouscom Highlights Potential of NOUS-209 to Intercept Cancer in Lynch Syndrome Carriers in Seminal Nature Medicine Publication

Lynch Syndrome (LS) is a common hereditary condition that significantly increases the lifetime risk of developing multiple cancersNOUS-209 is an off-the-shelf cancer immunotherapy designed to induce T ...
Longevity LIVE

The Key To Longveity Lies In Nature, Says Dr. Ash Kapoor

Dr. Ash Kapoor, founder of Levitas One, speaks about how cutting-edge longevity science meets ancient wisdom to help us live ...